trial · primary record
KPL-387
Recurrent Pericarditis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 120 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Posology: Proportion of participants free from Pericarditis Recurrence by Week 16 |
| Registry ID | NCT07288216 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:58.092Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07288216
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Kpl-387 · compound